💉 Gates Foundation pledges $7b for Africa; The WHO says the world’s teeth are in terrible shape

#219 | Solving the climate crisis with peatlands

Nov 18, 2022

∙ Paid

Hello, and welcome back to The Kable. Grab your copy right here and dig in for the weekend.

Last month, we reported on GSK's scaling back of its cell therapy ambitions after it culled deals with Lyell Immunopharma and Adaptimmune. At that time, we believed GSK's cell therapy deal signed in 2020 with Immatics was still on. Turns out GSK exited that deal t…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.